Phase 3 randomized first-line indolent trial (FIT) of consolidation of first remission with 90Y-ibritumomab tiuxetan (ZEVALIN) in advanced follicular non-Hodgkin's lymphoma (FL)

A. Hagenbeek; J. A. Radford; A. Van Hoof; U. Vitolo; P. Soubeyran; H. Tilly; P. C. Huijgens; A. Kolstad; M. Kunz; F. Morschhauser; FIT Investigators

Phase 3 randomized first-line indolent trial (FIT) of consolidation of first remission with 90Y-ibritumomab tiuxetan (ZEVALIN) in advanced follicular non-Hodgkin's lymphoma (FL)

A. Hagenbeek, J. A. Radford, A. Van Hoof, U. Vitolo, P. Soubeyran, H. Tilly, P. C. Huijgens, A. Kolstad, M. Kunz, F. Morschhauser, FIT Investigators

Research output: Contribution to journal › Article › peer-review

Original language	Undefined
Pages (from-to)	181-181
Number of pages	1
Journal	Annals of Oncology
Volume	19
Issue number	4
Publication status	Published - 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Hagenbeek, A., Radford, J. A., Van Hoof, A., Vitolo, U., Soubeyran, P., Tilly, H., Huijgens, P. C., Kolstad, A., Kunz, M., Morschhauser, F., & Investigators, FIT. (2008). Phase 3 randomized first-line indolent trial (FIT) of consolidation of first remission with 90Y-ibritumomab tiuxetan (ZEVALIN) in advanced follicular non-Hodgkin's lymphoma (FL). Annals of Oncology, 19(4), 181-181.

@article{3f2151b02d8a4d97ba806d3e0161ac3a,

title = "Phase 3 randomized first-line indolent trial (FIT) of consolidation of first remission with 90Y-ibritumomab tiuxetan (ZEVALIN) in advanced follicular non-Hodgkin's lymphoma (FL)",

author = "A. Hagenbeek and Radford, \{J. A.\} and \{Van Hoof\}, A. and U. Vitolo and P. Soubeyran and H. Tilly and Huijgens, \{P. C.\} and A. Kolstad and M. Kunz and F. Morschhauser and FIT Investigators",

year = "2008",

language = "Undefined",

volume = "19",

pages = "181--181",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier BV",

number = "4",

}

Hagenbeek, A, Radford, JA, Van Hoof, A, Vitolo, U, Soubeyran, P, Tilly, H, Huijgens, PC, Kolstad, A, Kunz, M, Morschhauser, F & Investigators, FIT 2008, 'Phase 3 randomized first-line indolent trial (FIT) of consolidation of first remission with 90Y-ibritumomab tiuxetan (ZEVALIN) in advanced follicular non-Hodgkin's lymphoma (FL)', Annals of Oncology, vol. 19, no. 4, pp. 181-181.

TY - JOUR

T1 - Phase 3 randomized first-line indolent trial (FIT) of consolidation of first remission with 90Y-ibritumomab tiuxetan (ZEVALIN) in advanced follicular non-Hodgkin's lymphoma (FL)

AU - Hagenbeek, A.

AU - Radford, J. A.

AU - Van Hoof, A.

AU - Vitolo, U.

AU - Soubeyran, P.

AU - Tilly, H.

AU - Huijgens, P. C.

AU - Kolstad, A.

AU - Kunz, M.

AU - Morschhauser, F.

AU - Investigators, FIT

PY - 2008

Y1 - 2008

UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000256693500346&KeyUID=WOS:000256693500346

M3 - Article

SN - 0923-7534

VL - 19

SP - 181

EP - 181

JO - Annals of Oncology

JF - Annals of Oncology

IS - 4

ER -

Phase 3 randomized first-line indolent trial (FIT) of consolidation of first remission with 90Y-ibritumomab tiuxetan (ZEVALIN) in advanced follicular non-Hodgkin's lymphoma (FL)

UN SDGs

Other files and links

Cite this